Literature DB >> 26776934

The true prognosis of resected distal cholangiocarcinoma.

Laetitia Courtin-Tanguy1,2,3, Michel Rayar1,2,4, Damien Bergeat1,2,3, Aude Merdrignac1,2,3, Yann Harnoy1,2,3, Karim Boudjema1,2,4, Bernard Meunier1,2, Laurent Sulpice1,2,3,4.   

Abstract

BACKGROUND: Prognosis of distal cholangiocarcinoma (DCC) after pancreaticoduodenectomy (PD) remains poorly assessed. The aims of this study were to describe the oncological results of PD in DCC and to compare its prognosis to pancreatic ductal adenocarcinoma (PDAC).
METHODS: All PD for periampullary carcinoma performed between January 2000 and March 2013 were extracted from a prospective database. Risk factors likely to influence overall (OS) and disease-free (DFS) survivals of DCC were assessed by multivariable analyses. The DCC and PDAC prognoses were compared after matching using propensity score (nearest neighbor matching).
RESULTS: Of the 290 patients analyzed, 56 had DCC, with a mean age of 65 ± 15 years. The median OS was 36.9 months. Recurrence occurred in 35 patients (67%), mostly in the liver (37%). The median DFS was 14.6 months. Combined organ resection was an independent risk factor for worse OS and DFS (P = 0.01 and P = 0.001, respectively). Matching analysis found no significant difference between DCC and PDAC in terms of OS (P = 0.284) or DFS (P = 0.438).
CONCLUSION: This first propensity analysis demonstrated that DCC and PDAC have the same prognosis, linked to the high rate of early recurrence, particularly associated with the need for combined organ resection. J. Surg. Oncol. 2016;113:575-580.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  distal cholangiocarcinoma; prognosis; recurrence

Mesh:

Year:  2016        PMID: 26776934     DOI: 10.1002/jso.24165

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.

Authors:  Ekaterina Petrova; Felix Rückert; Sebastian Zach; YinFeng Shen; Jürgen Weitz; Robert Grützmann; Uwe A Wittel; Frank Makowiec; Ulrich T Hopt; Peter Bronsert; Florian Kühn; Bettina M Rau; Roman E Izrailov; Igor E Khatkov; Hryhoriy Lapshyn; Louisa Bolm; Dirk Bausch; Tobias Keck; Ulrich F Wellner; Gabriel Seifert
Journal:  Langenbecks Arch Surg       Date:  2017-06-13       Impact factor: 3.445

2.  Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.

Authors:  Damien Bergeat; Olivier Turrini; Laetitia Courtin-Tanguy; Stéphanie Truant; Benjamin Darnis; Jean Robert Delpero; Jean-Yves Mabrut; Nicolas Regenet; Laurent Sulpice
Journal:  Langenbecks Arch Surg       Date:  2018-08-15       Impact factor: 3.445

3.  Proposal for a new T-stage classification system for distal cholangiocarcinoma: a 10-institution study from the U.S. Extrahepatic Biliary Malignancy Consortium.

Authors:  Lauren M Postlewait; Cecilia G Ethun; Nina Le; Timothy M Pawlik; Stefan Buettner; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Gerardo Vitiello; Kenneth Cardona; Shishir K Maithel
Journal:  HPB (Oxford)       Date:  2016-08-09       Impact factor: 3.647

4.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

5.  Factors influencing patterns of recurrence following pancreaticoduodenectomy for patients with distal bile duct cancer and ampulla of Vater cancer.

Authors:  Do Hyeon Lee; Hyoung Joo Kim; Chan Woo Cho; Sung Su Yun; Dong-Shik Lee
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-05-31

Review 6.  Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.

Authors:  Trond A Buanes
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

7.  Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma.

Authors:  Johannes Byrling; Roland Andersson; Agata Sasor; Gert Lindell; Daniel Ansari; Johan Nilsson; Bodil Andersson
Journal:  Ann Gastroenterol       Date:  2017-06-20

8.  Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma.

Authors:  Oliver Beetz; Michael Klein; Harald Schrem; Jill Gwiasda; Florian W R Vondran; Felix Oldhafer; Sebastian Cammann; Jürgen Klempnauer; Karl J Oldhafer; Moritz Kleine
Journal:  BMC Surg       Date:  2018-08-13       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.